|
1
|
Fallon UB, Ben-Shlomo Y, Elwood P, Ubbink
JB and Smith GD: Homocysteine and coronary heart disease in the
caerphilly cohort: A 10 year follow up. Heart. 85:153–158. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Suhara T, Fukuo K, Yasuda O, Tsubakimoto
M, Takemura Y, Kawamoto H, Yokoi T, Mogi M, Kaimoto T and Ogihara
T: Homocysteine enhances endothelial apoptosis via upregulation of
Fas-mediated pathways. Hypertension. 43:1208–1213. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lauricella AM, Quintana IL and Kordich LC:
Effects of homocysteine thiol group on fibrin networks: Another
possible mechanism of harm. Thromb Res. 107:75–79. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dardik R, Varon D, Tamarin I, Zivelin A,
Salomon O, Shenkman B and Savion N: Homocysteine and oxidized low
density lipoprotein enhance platelet adhesion to endothelial cells
under flow conditions: Distinct mechanisms of thrombogenic
modulation. Thromb Haemost. 83:338–344. 2000.PubMed/NCBI
|
|
5
|
Maron BA and Loscalzo J: The treatment of
hyperhomocysteinemia. Annu Rev Med. 60:39–54. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eberhardt RT, Forgione MA, Cap A, Leopold
A, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan
NI, et al: Endothelial dysfunction in a murine model of mild
hyperhomocyst(e)inemia. J Clin Invest. 106:483–491. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heydrick SJ, Weiss N, Thomas SR, Cap AP,
Pimentel DR, Loscalzo J and Keaney JF Jr: L-Homocysteine and
L-homocystine stereospecifically induce endothelial nitric oxide
synthase-dependent lipid peroxidation in endothelial cells. Free
Radic Biol Med. 36:632–640. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dayal S and Lentz SR: Role of redox
reactions in the vascular phenotype of hyperhomocysteinemic
animals. Antioxid Redox Signal. 9:1899–1909. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patumraj S, Tewit S, Amatyakul S,
Jariyapongskul A, Maneesri S, Kasantikul V and Shepro D:
Comparative effects of garlic and aspirin on diabetic
cardiovascular complications. Drug Deliv. 7:91–96. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kanth V Rajani, Uma Maheswara Reddy P and
Raju TN: Attenuation of streptozotocin- induced oxidative stress in
hepatic and intestinal tissues of Wistar rat by methanolic-garlic
extract. Acta Diabetol. 45:243–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Varmaghany S, Torshizi MA Karimi, Rahimi
S, Lotfollahian H and Hassanzadeh M: The effects of increasing
levels of dietary garlic bulb on growth performance, systolic blood
pressure, hematology, and ascites syndrome in broiler chickens.
Poult Sci. 94:1812–1820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ashraf R, Aamir K, Shaikh AR and Ahmed T:
Effects of garlic on dyslipidemia in patients with type 2 diabetes
mellitus. J Ayub Med Coll Abbottabad. 17:60–64. 2005.PubMed/NCBI
|
|
13
|
Liu DS, Gao W, Liang ES, Wang SL, Lin WW,
Zhang WD, Jia Q, Guo RC and Zhang JD: Effects of allicin on
hyperhomocysteinemia-induced experimental vascular endothelial
dysfunction. Eur J Pharmacol. 714:163–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
European Society of Hypertension-European
Society of Cardiology Guidelines Committee, . 2003 European society
of hypertension-European society of cardiology guidelines for the
management of arterial hypertension. J Hypertens. 21:1011–1053.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo J, Xiao F and Tang ZY: Determination
of homocysteine in plasma by high performance liquid
chromatography. Chin J Lab Med. 217–219. 2000.(In Chinese).
|
|
16
|
Wald DS, Law M and Morris JK: Homocysteine
and cardiovascular disease: Evidence on causality from a
meta-analysis. BMJ. 325:12022002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Homocysteine Studies Collaboration:
Homocysteine and risk of ischemic heart disease and stroke: A
meta-analysis. JAMA. 288:2015–2022. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mudd SH, Skovby F, Levy HL, Pettigrew KD,
Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R,
et al: The natural history of homocystinuria due to cystathionine
beta-synthase deficiency. Am J Hum Genet. 37:1–31. 1985.PubMed/NCBI
|
|
19
|
Nygård O, Nordrehaug JE, Refsum H, Ueland
PM, Farstad M and Vollset SE: Plasma homocysteine levels and
mortality in patients with coronary artery disease. N Eng J Med.
337:230–236. 1997. View Article : Google Scholar
|
|
20
|
de Koning AB Lawrence, Werstuck GH, Zhou J
and Austin RC: Hyperhomocysteinemia and its role in the development
of atherosclerosis. Clin Biochem. 36:431–441. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blom HJ, Kleinveld HA, Boers GH, Demacker
PN, Har-Lemmers HL, Te Poele-Pothoff MT and Trijbels JM: Lipid
peroxidation and susceptibility of low-density lipoprotein to in
vitro oxidation in hyperhomocysteinaemia. Eur J Clin Invest.
25:149–154. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou J and Austin RC: Contributions of
hyperhomocysteinemia to atherosclerosis: Causal relationship and
potential mechanisms. Biofactors. 35:120–129. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Skurk C and Walsh K: Death receptor
induced apoptosis: A new mechanism of homocysteine-mediated
endothelial cell cytotoxicity. Hypertension. 43:1168–1170. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ohaeri OC and Adoga GI: Anticoagulant
modulation of blood cells and platelet reactivity by garlic oil in
experimental diabetes mellitus. Biosci Rep. 26:1–6. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanth V Rajani, Uma Maheswara Reddy P and
Raju TN: Attenuation of streptozotocin-induced oxidative stress in
hepatic and intestinal tissues of Wistar rat by methanolic-garlic
extract. Acta Diabetol. 45:243–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu MW and Tang SL: Curative effects of
allicin on 59 hyperlipidemia patients. Chin General Practice.
496–497. 2002.(In Chinese).
|
|
27
|
Tan B, Hu YS, Hang H, Yu ZL and Li YJ:
Protecting function of Thera-Garlicin on injury of blood vessel
endothelium in rats with diabetes mellitus. Modern J Integrated
Traditional Chin Western Med. 3335–3336. 2006.(In Chinese).
|
|
28
|
Baluchnejadmojarad T, Roghani M,
Homayounfar H and Hosseini M: Beneficial effect of aqueous garlic
extract on the vascular reactivity of streptozotocin-diabetic rats.
J Ethnopharmacol. 85:139–144. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin YL and Yang SF: Effect of allicin on
apoptosis and MAPK of heart cell in diabetic rats. J Lialaoning
Univ TCM. 13:56–58. 2011.
|
|
30
|
Wang SL, Liu DS, Guo RC and Zhang WD:
Effect of garlicin on the serum homocysteine level in rats. J
Shandong Univ. 389–391. 2006.(In Chinese).
|
|
31
|
Benavides GA, Squadrito GL, Mills RW,
Patel HD, Isbell ST, Patel RP, Darley-Usmar VM, Doeller JE and
Kraus DW: Hydrogen sulfide mediates the vasoactivity of garlic.
Proc Natl Acad Sci USA. 104:pp. 17977–17982. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Adams MR, Nakagomi A, Keech A, Robinson J,
McCredie R, Bailey BP, Freedman BS and Celermajer DS: Carotid
intima-media thickness is only weakly correlated with the extent
and severity of coronary artery disease. Circulation. 92:2127–2134.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chambless LE, Heiss G, Folsom AR, Rosamond
W, Szklo M, Sharrett AR and Clegg LX: Association of coronary heart
disease incidence with carotid arterial wall thickness and major
risk factors: The Atherosclerosis Risk in Communities (ARIC) Study,
1987–1993. Am J Epidemiol. 146:483–494. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Burke GL, Evans GW, Riley WA, Sharrett RA,
Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM and Heiss
G: Arterial wall thickness is associated with prevalent
cardiovascular disease in middle-aged adults. The Atherosclerosis
Risk in Communities (ARIC) Study. Stroke. 26:386–391. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Karpe F, Boquist S, Tang R, Bond GM, de
Faire U and Hamsten A: Remnant lipoproteins are relatedto
intima-media thickness of the carotid artery independently of LDL
cholesterol and plasma triglycerides. J Lipid Res. 42:17–21.
2001.PubMed/NCBI
|
|
36
|
Albert CM, Cook NR, Gaziano JM, Zaharris
E, MacFadyen J, Danielson E, Buring JE and Manson JE: Effect of
folic acid and B vitamins on risk of cardiovascular events and
total mortality among women at high risk for cardiovascular
disease: A randomized trial. JAMA. 299:2027–2036. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ebbing M, Bleie Ø, Ueland PM, Nordrehaug
JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK and Nygård O:
Mortality and cardiovascular events in patients treated with
homocysteine-lowering B vitamins after coronary angiography: A
randomized controlled trial. JAMA. 300:795–804. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lonn E, Yusuf S, Arnold MJ, Sheridan P,
Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, et
al: Homocysteine lowering with folic acid and B vitamins in
vascular disease. N Engl J Med. 354:1567–1577. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Toole JF, Malinow MR, Chambless LE, Spence
JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH and Stampfer M:
Lowering homocysteine in patients with ischemic stroke to prevent
recurrent stroke, myocardial infarction, and death: The vitamin
intervention for stroke prevention (VISP) randomized controlled
trial. JAMA. 291:565–575. 2004. View Article : Google Scholar : PubMed/NCBI
|
